Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 209

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy?

Niederberger, Ellen, Geisslinger, Gerd·2008·The FASEB Journal

Abstract

Several studies indicate that the nuclear factor‐kappa B (NF‐κB) ‐activation cascade plays a crucial role not only in immune responses, inflammation, and apoptosis but also in the development and processing of pathological pain. Accordingly, a pharmacological intervention into this pathway may have antinociceptive effects and could provide novel treatment strategies for pain and inflammation. In this review we summarize the role of NF‐κB in the nervous system, its impact on nociception, and several approaches that investigated the effects of various modulators of the classical I‐κB‐kinase‐NF‐κB signal transduction pathway in inflammatory nociception and neuropathic pain. The results indicate that NF‐κB has an impact on nociceptive transmission and processing and that a number of substances that inhibit the NF‐κB‐activating cascade are capable of reducing the nociceptive response in different animal models. Therefore, a modulation of specific participants in the NF‐κB signal transduction might exert a useful approach for the development of new painkillers.—Niederberger, E., Geisslinger, G. The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy? FASEB J. 22, 3432–3442 (2008)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.08-109355

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 209

Metadata

Authors
Niederberger, E., & Geisslinger, G.
Venue
The FASEB Journal
Publisher
Wiley
Published
2008-06-17
Volume
22
Issue
10
Pages
3432-3442
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1999405426
Cited by
209
References
8
FWCI
4.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy? https://app.cochat.ai/papers/10.1096/fj.08-109355
The paper
Niederberger, E., & Geisslinger, G. (2008). The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy? The FASEB Journal. https://doi.org/10.1096/fj.08-109355

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.